Basel, Switzerland

Steven McIntyre

This inventor holds 1 USPTO granted patent. Top assignee: Vernalis Limited. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven McIntyre. Retrieved from https://idiyas.com/inventor/steven-mcintyre-ekgr691m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Steven McIntyre

Introduction

Steven McIntyre is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of novel processes for chemical compounds. His work exemplifies the intersection of innovation and practical application in the pharmaceutical industry.

Latest Patents

One of Steven McIntyre's key patents is titled "Process for the production of R-(+)-6-carboxamido-3-N-methylamino-1,2,3,4-tetrahydrocarbazole." This invention relates to a novel process for the preparation of R-(+)-6-carboxamido-3-N-methylamino-1,2,3,4-tetrahydrocarbazole. The process involves resolving an enantiomeric mixture of a specific compound, showcasing his expertise in chemical synthesis.

Career Highlights

Steven McIntyre is associated with Vernalis Limited, a company known for its focus on drug discovery and development. His role at Vernalis Limited has allowed him to contribute to various innovative projects and advancements in the pharmaceutical sector. With 1 patent to his name, he has established himself as a valuable asset in his field.

Collaborations

Some of his notable coworkers include Ian Brackenridge and Caroline McGee. Their collaborative efforts have likely contributed to the success of various projects within the company.

Conclusion

Steven McIntyre's innovative work in the field of chemistry and his contributions to Vernalis Limited highlight the importance of collaboration and creativity in driving advancements in pharmaceuticals. His patent reflects a commitment to developing new processes that can have a significant impact on drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…